With Beyond Meat finally having returned to its IPO-day price range, the stock finally looks fairly valued. BYND may stay here for now, but if its earnings outlook improves then it could once again explode higher. I think this stock has a lot of upside potential in the next two years, with analysts currently forecasting huge earnings growth. The current analyst summary score is pretty bad, at 1.1/10. However, it has a "buy" rating from Zacks, which is one of the most accurate analyst firms, and a low summary score means there's a lot of opportunity for upgrades to move the stock price. I also see a fair amount of bullish divergence on the chart.
註釋
BYND has been weak ever since the FDA approved its rival Impossible Burger's soy leghemoglobin product, but it appears to be setting up for a bounce today. Enter on a green close today.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。